XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.25.3

EQUITY AWARDS | 6 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
EQUITY AWARDS | (I) EQUITY AWARDS On August 3, 2023, our stockholders approved the Eagle Materials Inc. 2023 Equity Incentive Plan (the 2023 Plan), which reserves 1,425,000 shares for future grants of stock awards. Under the terms of the 2023 Plan, we can issue equity awards, including stock options, restricted stock units, restricted stock, and stock appreciation rights to employees of the Company, members of the Board of Directors, and consultants, independent contractors, and agents of the Company. The Compensation Committee of our Board of Directors (Compensation Committee) specifies grant terms for awards under the Plan. Fiscal 2026 Equity Awards In May 2025, the Compensation Committee awarded to certain officers and key employees an aggregate of 29,273 performance stock units and 14,712 performance stock options, which represents achievement of the target level of performance (collectively, the Performance Stock Awards or PSAs). For the Performance Stock Awards to be earned, the Company must achieve performance vesting criteria as modified based on the Company’s average absolute total stockholder return during the performance period. The performance vesting criteria are based upon certain levels of average annual return on equity (as defined in the Performance Stock Award Agreements) ranging from 10.0% to 20.0% measured at the end of fiscal 2028 (three-year performance period) as modified by total stockholder return. Performance outcomes (taking into account both criteria) will result in a threshold vesting percentage of 50% of target and maximum performance will result in a vesting percentage of 200% of target. If the threshold vesting percentage is not achieved none of the Performance Stock Awards will be earned. Our Performance Stock Awards are evaluated on a quarterly basis with adjustments to compensation expense based on the likelihood of the performance targets being achieved or exceeded. The maximum expense for our outstanding Performance Stock Awards is approximately $17.4 million. Any forfeitures are recognized as a reduction to expense in the period in which they occur. The fair value of the above Performance Stock Awards was determined using a Monte Carlo simulation. The following are key inputs in the Monte Carlo analysis for the Fiscal 2026 Employee Performance Stock Awards.
|  | Fiscal 2026 |
Measurement Period (in years) |  |  | 2.86 |
Risk-Free Interest Rate |  |  | 4.0 | %
Dividend Yield |  |  | 0.5 | %
Volatility |  |  | 31.3 | %
Estimated Fair Value of Market-Based PSAs at Grant Date |  | $ | 213.66 |
In addition to the Performance Stock Awards discussed above, the Compensation Committee approved the granting to certain officers and key employees an aggregate of 14,712 ti me-vesting stock options which vest ratably over three years (the Fiscal 2026 Employee Time-Vesting Stock Option Grant) an d 29,273 s hares of time-vesting restricted stock units, which vest ratably over three years (the Fiscal 2026 Employee Restricted Stock Unit Time-Vesting Award). The Fiscal 2026 Employee Restricted Stock Unit Time-Vesting Award was valued at the closing price of the stock on the grant date and is being expensed over a three-year period. The Fiscal 2026 Employee Time-Vesting Stock Option Grant was valued at the grant date using the Black-Scholes option pricing model, which used similar inputs as the Monte Carlo analysis shown above. In addition to the stock awards described above, we may issue additional equity awards, including stock options, restricted stock, and restricted stock units, to certain employees from time to time. Any options issued are valued using the Black-Scholes options pricing model on the grant date and expensed over the vesting period, while restricted stock and restricted stock units are valued using the closing price on the grant date and expensed over the vesting period. STOCK OPTIONS Stock option expense for all outstanding stock option awards totaled approximatel y $0.5 m illion an d $0.9 mi llion for the three and six months ended September 30, 2025, respectively and $0.3 million and $0.6 million for the three and six months ended September 30, 2024, respectively. At September 30, 2025, there was approximately $3.2 m illion of unrecognized compensation cost related to outstanding stock options, which is expected to be recognized over a weighted-average period of 2.2 ye ars. The following table represents stock option activity for the six months ended September 30, 2025:
|  | Number of Shares |  |  |  | Weighted- Average Exercise Price |
Outstanding Options at March 31, 2025 |  |  | 184,233 |  |  | $ |  | 95.75 |
Granted |  |  | 29,424 |  |  | $ |  | 213.66 |
Exercised |  |  | (6,003 | ) |  | $ |  | 79.73 |
Cancelled |  |  | — |  |  | $ |  | — |
Outstanding Options at September 30, 2025 |  |  | 207,654 |  |  | $ |  | 112.92 |
Options Exercisable at September 30, 2025 |  |  | 160,325 |  |  |  |  |
Weighted-Average Fair Value of Options Granted During the Year |  |  |  |  | $ |  | 90.94 |
The following table summarizes information about stock options outstanding at September 30, 2025:
|  | Options Outstanding |  |  | Options Exercisable |
Range of Exercise Prices |  | Number of Shares Outstanding |  |  | Weighted- Average Remaining Contractual Life (in years) |  |  | Weighted- Average Exercise Price |  |  | Number of Shares Outstanding |  |  | Weighted- Average Exercise Price |
$59.32 - $81.28 |  |  | 82,057 |  |  |  | 4.34 |  |  | $ | 61.78 |  |  |  | 82,057 |  |  | $ | 61.78 |
$91.21 - $100.88 |  |  | 32,852 |  |  |  | 2.76 |  |  | $ | 94.95 |  |  |  | 32,852 |  |  | $ | 94.95 |
$118.27 - $139.25 |  |  | 48,931 |  |  |  | 6.61 |  |  | $ | 126.59 |  |  |  | 36,079 |  |  | $ | 126.93 |
$143.09 - $261.76 |  |  | 43,814 |  |  |  | 2.51 |  |  | $ | 206.91 |  |  |  | 9,337 |  |  | $ | 182.32 |
|  |  | 207,654 |  |  |  | 4.24 |  |  | $ | 112.92 |  |  |  | 160,325 |  |  | $ | 90.26 |
At September 30, 2025, the aggregate intrinsic value of the outstanding and exercisable options was approximately $25.0 milli on and $22.9 million, respectively. The total intrinsic value of options exercised during the six months ended September 30, 2025, was approximately $0.8 million. RESTRICTED STOCK UNITS AND RESTRICTED STOCK The following table summarizes the activity for restricted stock units and nonvested restricted stock during the six months ended September 30, 2025:
|  | Number of Shares |  |  |  | Weighted- Average Grant Date Fair Value |
Restricted Stock Units and Nonvested Restricted Stock at March 31, 2025 |  |  | 194,099 |  |  | $ |  | 150.56 |
Granted |  |  | 70,167 |  |  | $ |  | 215.28 |
Vested |  |  | (73,347 | ) |  | $ |  | 107.09 |
Cancelled |  |  | — |  |  | $ |  | — |
Restricted Stock Units and Nonvested Restricted Stock at September 30, 2025 |  |  | 190,919 |  |  | $ |  | 123.94 |
Expense related to restricted stock units and restricted stock wa s approximately $5.0 million and $9.4 m illion for the three and six months ended September 30, 2025, respectively, and $4.6 million and $8.8 million for the three and six months ended September 30, 2024, respectively. At September 30, 2025, there was approximately $27.8 million of unearned compensation from restricted stock units and nonvested restricted shares, which will be recognized over a weighted-average per iod of 1.6 year s. The number of shares available for future grants of stock options, restricted stock units, stock appreciation rights, and restricted stock under the Plan wa s 1,244,080 at S eptember 30, 2025.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration